Using Media to Promote Public Awareness of Early Detection of Kaposi's Sarcoma in Africa.
Journal
Journal of oncology
ISSN: 1687-8450
Titre abrégé: J Oncol
Pays: Egypt
ID NLM: 101496537
Informations de publication
Date de publication:
2020
2020
Historique:
received:
09
08
2019
revised:
20
01
2020
accepted:
06
02
2020
entrez:
14
4
2020
pubmed:
14
4
2020
medline:
14
4
2020
Statut:
epublish
Résumé
Despite its hallmark cutaneous presentation, most Kaposi's sarcoma (KS) in Africa is diagnosed too late for effective treatment. Early diagnosis will only be achievable if patients with KS present earlier for care. We hypothesized that public awareness about KS can be enhanced through exposure to common media. We developed educational messages regarding early detection of KS for the general African public portraying a three-part theme: "Look" (regularly examine one's skin/mouth), "Show" (bring to the attention of a healthcare provider any skin/mouth changes), and "Test" (ask for a biopsy for definitive diagnosis). We packaged the messages in three common media forms (comic strips, radio, and video) and tested their effect on increasing KS awareness among adults attending markets in Uganda. Participants were randomized to a single exposure to one of the media and evaluated for change in KS-related knowledge and attitudes. Among 420 participants, media exposure resulted in increased ability to identify KS (from 0.95% pretest to 46% posttest); awareness that anyone is at risk for KS (29% to 50%); belief that they may be at risk (63% to 76%); and knowledge that definitive diagnosis requires biopsy (23% to 51%) (all Exposure to media featuring a theme of "Look," "Show," and "Test" resulted in changes in knowledge and attitudes concerning KS among the general public in Uganda. High incidence and poor survival of KS in Africa are an impetus to further evaluate these media, which are freely available online.
Sections du résumé
BACKGROUND
BACKGROUND
Despite its hallmark cutaneous presentation, most Kaposi's sarcoma (KS) in Africa is diagnosed too late for effective treatment. Early diagnosis will only be achievable if patients with KS present earlier for care. We hypothesized that public awareness about KS can be enhanced through exposure to common media.
METHODS
METHODS
We developed educational messages regarding early detection of KS for the general African public portraying a three-part theme: "Look" (regularly examine one's skin/mouth), "Show" (bring to the attention of a healthcare provider any skin/mouth changes), and "Test" (ask for a biopsy for definitive diagnosis). We packaged the messages in three common media forms (comic strips, radio, and video) and tested their effect on increasing KS awareness among adults attending markets in Uganda. Participants were randomized to a single exposure to one of the media and evaluated for change in KS-related knowledge and attitudes.
RESULTS
RESULTS
Among 420 participants, media exposure resulted in increased ability to identify KS (from 0.95% pretest to 46% posttest); awareness that anyone is at risk for KS (29% to 50%); belief that they may be at risk (63% to 76%); and knowledge that definitive diagnosis requires biopsy (23% to 51%) (all
CONCLUSION
CONCLUSIONS
Exposure to media featuring a theme of "Look," "Show," and "Test" resulted in changes in knowledge and attitudes concerning KS among the general public in Uganda. High incidence and poor survival of KS in Africa are an impetus to further evaluate these media, which are freely available online.
Identifiants
pubmed: 32280342
doi: 10.1155/2020/3254820
pmc: PMC7115145
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3254820Subventions
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA190153
Pays : United States
Informations de copyright
Copyright © 2020 Miriam Laker-Oketta et al.
Déclaration de conflit d'intérêts
The authors declare no potential conflicts of interest.
Références
Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):971-8
pubmed: 10566551
BMC Cancer. 2017 Dec 2;17(1):806
pubmed: 29197357
Cancer Epidemiol. 2015 Feb;39(1):1-7
pubmed: 25468643
Health Promot Int. 2015 Sep;30(3):647-57
pubmed: 24474424
Curr Oncol Rep. 2012 Oct;14(5):458-67
pubmed: 22907282
Psychooncology. 2017 Oct;26(10):1455-1462
pubmed: 27218238
BMJ Open. 2015 Sep 15;5(9):e008158
pubmed: 26373399
Int J Equity Health. 2012 Dec 29;11:83
pubmed: 23273140
Lancet. 2015 Oct 17;386(10003):1521-2
pubmed: 26530606
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
PLoS One. 2014 Mar 14;9(3):e91020
pubmed: 24632813
Int J Cancer. 2014 Feb 15;134(4):913-24
pubmed: 23913595
BMC Cancer. 2018 Mar 21;18(1):312
pubmed: 29562894
Int J Cancer. 2018 Apr 15;142(8):1528-1535
pubmed: 29105744
PLoS One. 2017 Feb 13;12(2):e0171024
pubmed: 28192444
Parasitology. 2017 Oct;144(12):1643-1648
pubmed: 28653590
BMJ. 1988 Aug 6;297(6645):388-91
pubmed: 3408978
J Health Commun. 2009 Jan-Feb;14(1):15-42
pubmed: 19180369
Cancer Causes Control. 2004 Jun;15(5):453-63
pubmed: 15286465
Clin Infect Dis. 2010 Aug 1;51(3):342-9
pubmed: 20572760
Psychol Bull. 1992 May;111(3):455-74
pubmed: 1594721
Cancer. 2012 Nov 1;118(21):5395-402
pubmed: 22517033
Melanoma Res. 2006 Aug;16(4):341-5
pubmed: 16845330
Ann Intern Med. 2009 Feb 3;150(3):194-8
pubmed: 19189909
CA Cancer J Clin. 1985 May-Jun;35(3):130-51
pubmed: 3921200
J Glob Oncol. 2017 Mar 8;3(5):497-501
pubmed: 29094088
Lancet Oncol. 2013 Apr;14(4):e142-51
pubmed: 23561745
BMJ Open. 2016 Jan 04;6(1):e009905
pubmed: 26729392
BMJ. 2003 Feb 15;326(7385):367
pubmed: 12586670
Cancer Treat Res. 2016;167:107-29
pubmed: 26601860
Health Educ Res. 2015 Oct;30(5):786-96
pubmed: 26336906
J Am Acad Dermatol. 2017 Jan;76(1):129-139.e10
pubmed: 27707591
Am J Epidemiol. 2002 Jan 15;155(2):176-84
pubmed: 11790682
Prog Clin Biol Res. 1983;120:497-508
pubmed: 6878305
JAMA. 2016 Jul 26;316(4):436-47
pubmed: 27458949
Cancer Med. 2016 May;5(5):914-28
pubmed: 26823008
Am J Prev Med. 2007 Jun;32(6):517-24
pubmed: 17533068
BMC Res Notes. 2015 Sep 15;8:440
pubmed: 26374100
Br J Dermatol. 1990 Jul;123(1):85-92
pubmed: 2390498
Ann Surg. 1970 Nov;172(5):902-8
pubmed: 5477666
J Infect Dis. 2016 May 1;213 Suppl 3:S79-85
pubmed: 26908717
J Cancer Educ. 2017 Mar;32(1):35-42
pubmed: 26637473
Eur J Cancer Care (Engl). 2015 Jul;24(4):503-13
pubmed: 24923866
BMC Med Res Methodol. 2008 Oct 30;8:70
pubmed: 18973665
J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):547-54
pubmed: 25393941
JAMA. 2016 Jul 26;316(4):429-35
pubmed: 27458948
Br Med J. 1979 Jan 27;1(6158):253-4
pubmed: 421056